45 related articles for article (PubMed ID: 30145803)
1. miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1.
Wan P; Chi X; Du Q; Luo J; Cui X; Dong K; Bing Y; Heres C; Geller DA
J Cell Biochem; 2018 Dec; 119(12):9720-9729. PubMed ID: 30145803
[TBL] [Abstract][Full Text] [Related]
2. Identification of tumor-suppressive miRNAs that target amino acid transporter LAT1 and exhibit anti-proliferative effects on cholangiocarcinoma cells.
Liu X; Nishikubo K; Ohgaki R; Okanishi H; Okuda S; Xu M; Kanai Y
J Pharmacol Sci; 2024 Apr; 154(4):301-311. PubMed ID: 38485348
[TBL] [Abstract][Full Text] [Related]
3. PIMREG, a Marker of Proliferation, Facilitates Aggressive Development of Cholangiocarcinoma Cells Partly Through Regulating Cell Cycle-Related Markers.
Jiang ZM; Li HB; Chen SG
Technol Cancer Res Treat; 2020; 19():1533033820979681. PubMed ID: 33356974
[TBL] [Abstract][Full Text] [Related]
4. Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis.
Zhang C; Qin C
Hum Cell; 2024 May; 37(3):739-751. PubMed ID: 38416277
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer.
Su J; Tan S; Li Y; Chen X; Liu J; Luo Y; Pan C; Zhang L
Front Pharmacol; 2024; 15():1413699. PubMed ID: 38915471
[TBL] [Abstract][Full Text] [Related]
6. Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin.
Perevalova AM; Gulyaeva LF; Pustylnyak VO
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396830
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of curcumin against CD44
Panahizadeh R; Vatankhah MA; Jeddi F; Arabzadeh A; Nejati-Koshki K; Salimnejad R; Najafzadeh N
Avicenna J Phytomed; 2023; 13(4):429-441. PubMed ID: 37663388
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion.
Lucarini V; Nardozi D; Angiolini V; Benvenuto M; Focaccetti C; Carrano R; Besharat ZM; Bei R; Masuelli L
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371856
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-383: A tumor suppressor miRNA in human cancer.
Jafarzadeh A; Noori M; Sarrafzadeh S; Tamehri Zadeh SS; Nemati M; Chatrabnous N; Jafarzadeh S; Hamblin MR; Jafari Najaf Abadi MH; Mirzaei H
Front Cell Dev Biol; 2022; 10():955486. PubMed ID: 36313570
[TBL] [Abstract][Full Text] [Related]
10. RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial-Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma.
Zhang L; Zhang Y; Shen D; Chen Y; Feng J; Wang X; Ma L; Liao Y; Tang L
J Hepatocell Carcinoma; 2022; 9():405-422. PubMed ID: 35592242
[TBL] [Abstract][Full Text] [Related]
11. Circ_0005231 promotes the progression of esophageal squamous cell carcinoma via sponging miR-383-5p and regulating KIAA0101.
Sun Z; Zhang S; Zhang N; Wang J; Wang J; Liu J
Thorac Cancer; 2022 Jun; 13(12):1751-1762. PubMed ID: 35524161
[TBL] [Abstract][Full Text] [Related]
12. A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis.
Yi Q; Xie W; Sun W; Sun W; Liao Y
J Cancer; 2022; 13(1):313-324. PubMed ID: 34976192
[TBL] [Abstract][Full Text] [Related]
13. Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology.
Manne A; Woods E; Tsung A; Mittra A
Front Oncol; 2021; 11():768009. PubMed ID: 34868996
[TBL] [Abstract][Full Text] [Related]
14. miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway.
He B; Wu C; Sun W; Qiu Y; Li J; Liu Z; Jing T; Wang H; Liao Y
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34558639
[TBL] [Abstract][Full Text] [Related]
15. The Role of microRNAs in Cholangiocarcinoma.
Shi T; Morishita A; Kobara H; Masaki T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299246
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Biomarkers for Cholangiocarcinoma.
Rodrigues PM; Vogel A; Arrese M; Balderramo DC; Valle JW; Banales JM
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203269
[TBL] [Abstract][Full Text] [Related]
17. miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.
Jiang ZL; Zhang FX; Zhan HL; Yang HJ; Zhang SY; Liu ZH; Jiang Y; Lv LZ; Ke RS
Biochem Genet; 2022 Feb; 60(1):223-240. PubMed ID: 34169384
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA Circ0021205 Promotes Cholangiocarcinoma Progression Through MiR-204-5p/RAB22A Axis.
Tu J; Chen W; Zheng L; Fang S; Zhang D; Kong C; Yang Y; Qiu R; Zhao Z; Lu C; Lu X; Ji J
Front Cell Dev Biol; 2021; 9():653207. PubMed ID: 34012964
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNAs: Role in Testicular Cancers.
Bresesti C; Vezzoli V; Cangiano B; Bonomi M
Front Oncol; 2021; 11():605606. PubMed ID: 33767982
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
